Skip to main content
Journal cover image

ASO Visual Abstract: Re-Excision After Unplanned Excision of Soft Tissue Sarcoma Is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease.

Publication ,  Journal Article
Traweek, RS; Martin, AN; Rajkot, NF; Guadagnolo, BA; Bishop, AJ; Lazar, AJ; Keung, EZ; Torres, KE; Hunt, KK; Feig, BW; Roland, CL; Scally, CP
Published in: Ann Surg Oncol
January 2023

Duke Scholars

Published In

Ann Surg Oncol

DOI

EISSN

1534-4681

Publication Date

January 2023

Volume

30

Issue

1

Start / End Page

492

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Traweek, R. S., Martin, A. N., Rajkot, N. F., Guadagnolo, B. A., Bishop, A. J., Lazar, A. J., … Scally, C. P. (2023). ASO Visual Abstract: Re-Excision After Unplanned Excision of Soft Tissue Sarcoma Is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease. Ann Surg Oncol, 30(1), 492. https://doi.org/10.1245/s10434-022-12415-1
Traweek, Raymond S., Allison N. Martin, Nikita F. Rajkot, B Ashleigh Guadagnolo, Andrew J. Bishop, Alexander J. Lazar, Emily Z. Keung, et al. “ASO Visual Abstract: Re-Excision After Unplanned Excision of Soft Tissue Sarcoma Is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease.Ann Surg Oncol 30, no. 1 (January 2023): 492. https://doi.org/10.1245/s10434-022-12415-1.
Traweek, Raymond S., et al. “ASO Visual Abstract: Re-Excision After Unplanned Excision of Soft Tissue Sarcoma Is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease.Ann Surg Oncol, vol. 30, no. 1, Jan. 2023, p. 492. Pubmed, doi:10.1245/s10434-022-12415-1.
Traweek RS, Martin AN, Rajkot NF, Guadagnolo BA, Bishop AJ, Lazar AJ, Keung EZ, Torres KE, Hunt KK, Feig BW, Roland CL, Scally CP. ASO Visual Abstract: Re-Excision After Unplanned Excision of Soft Tissue Sarcoma Is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease. Ann Surg Oncol. 2023 Jan;30(1):492.
Journal cover image

Published In

Ann Surg Oncol

DOI

EISSN

1534-4681

Publication Date

January 2023

Volume

30

Issue

1

Start / End Page

492

Location

United States

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis